Skip to content

MDMA: all studies

Page 342 of 345: studies 3,411 to 3,420 of 3,446, newest first. Back to the MDMA overview

Research

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine.

Pharmacology, Biochemistry, and Behavior March 1991 D J McKenna, X M Guan, A T Shulgin

The effect of various analogues of the neurotoxic amphetamine derivative, MDA (3,4-methylenedioxyamphetamine) on carrier-mediated, calcium-independent release of 3H-5-HT and 3H-DA from rat brain synaptosomes was investigated. Both enantiomers of the neurotoxic analogues MDA and MDMA (3,4-methylenedioxymethamphetamine) induce synaptosomal release of 3H-5-HT and 3H-DA in vitro. The release of...

Oracular Art and the Global Telecommunications Net

Leonardo 1991 Timothy Michael O’Neill

A s an artist exploring altered states of awareness since 1975, both solo and in tandem with shamanistic performance artist Kristine Ambrosia, I have been forced constantly to move between the actual experience of oracular states in performance art and the specialized researches necessary to communicate my experience and improve the quality of perception of my inner reality. My initial wave of...

Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.

Psychopharmacology 1991 C W Callaway, M P Johnson, L H Gold et al. 70 citations

Derivatives of amphetamine are potent releasers of both dopamine (DA) and serotonin (5-HT), but the relative contributions of DA and 5-HT release to the behavioral effects of these drugs have not been established. Previously, S-(+)3,4-methylenedioxymethamphetamine (S-(+)MDMA) was found to produce locomotor hyperactivity in rats which was dependent on 5-HT release. The present study found that...

The transformation of consciousness in ritual performances: some thoughts and questions

Cambridge University Press eBooks May 25, 1990 Barbara G. Myerhoff 38 citations

What do we mean by transformation in consciousness? Everyday usage suggests a transformation is a major and lasting change: in structure, appearance, character or function. One becomes something else, and since we are emphasizing consciousness, we must add, one has an altered state of consciousness, a new perception of oneself or one's socio/physical world, a conversion in awareness, belief,...

Nonneurotoxic tetralin and indan analogs of 3,4-(methylenedioxy)amphetamine (MDA)

Journal of Medicinal Chemistry February 1, 1990 David E. Nichols, William K. Brewster, Michael P. Johnson et al. 83 citations

Four cyclic analogues of the psychoactive phenethylamine derivative 3,4-(methylenedioxy)amphetamine were studied. These congeners, 5,6- and 4,5-(methylenedioxy)-2-aminoindan (3a and 4a, respectively), and 6,7- and 5,6-(methylenedioxy)-2-aminotetralin (3b and 4b, respectively) were tested for stimulus generalization in the two-lever drug-discrimination paradigm. Two groups of rats were trained...

DOI: 10.1021/jm00164a037 (opens in new tab) Citation Icon Information retrieval Library science

Cross-Reactivity of Amphetamine Analogues with Roche Abuscreen Radioimmunoassay Reagents

Journal of Analytical Toxicology 1990 John T. Cody 22 citations

Cross-reactivity of amphetamine analogues with the Abuscreen amphetamine radioimmunoassay reagents was determined for both the standard and high specificity antibody systems. Compounds tested included 2-methoxyamphetamine, 4-hydroxymethamphetamine, 2,5-dimethoxyamphetamine (DMA), 4-bromo-2,5-dimethoxyamphetamine (DOB), 4-bromo-2,5-dimethoxy-beta-phenethylamine (BDMPEA),...

Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA) analogues.

Pharmacology, Biochemistry, and Behavior November 1989 D E Nichols, Robert Oberlender, K Burris et al.

The 3,4-ethylidenedioxy and 3,4-isopropylidenedioxy analogues, EDA and IDA, respectively, of 3, 4-methylenedioxyamphetamine (MDA) were compared to MDA in drug-stimulated [3H]-serotonin overflow from prelabelled rat hippocampal slices, [3H]-dopamine overflow from prelabelled rat caudate slices, in their ability to displace the 5-HT2 agonist R-[125I]-DOI from rat brain cortical binding sites....

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.

Psychopharmacology 1989 B Sadzot, J M Baraban, Richard A Glennon et al.

It has been shown that the hallucinogenic potencies of LSD, the phenylisopropylamines, such as DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) and DOI (4-iodo-2,5-dimethoxyphenylisopropylamine), and the indolealkylamines, such as DMT (dimethyltryptamine) and 5-OMe-DMT (5-methoxy-dimethyltryptamine), strongly correlate with their in vitro 5-HT2 receptor binding affinities in rat cortical...

The language of altered states.

The Journal of Nervous and Mental Disease July 1, 1988 T E Oxman, S D Rosenberg, P P Schnurr et al.

To compare the subjective experience of different forms of altered states of consciousness, computerized content analysis was applied to 66 autobiographical accounts of schizophrenia, hallucinogenic drug states, or mystical ecstasy and to 28 autobiographical control accounts of important personal experiences. The patterns of lexical choice used by the four groups were significantly different in...

Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.

Pharmacology, Biochemistry, and Behavior March 1988 Richard A Glennon, M Yousif, G Patrick

Using a standard two-lever operant procedure, groups of rats were trained to discriminate intraperitoneal doses of the phenylisopropylamines (+)amphetamine (1.0 mg/kg) or racemic 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM; 1.0 mg/kg) from saline using a VI 15-sec schedule of reinforcement for food reward. Once trained, the animals were administered doses of several methylenedioxy...